Companion Diagnostics: Defining, Trending, and Predicting

Please join us for a regulatory, intellectual property, and business strategy review of the latest issues affecting companion diagnostics and how they will influence pharmaceutical, biotech, and medical device decisionmakers going forward.

This one-hour webinar will focus on issues for diagnostic and biomarker companies, pharma, and others with an interest in personalized medicine in the life sciences field.

Topics will include:

• What companion diagnostics are and are not
• US Food and Drug Administration regulatory pathway considerations
• Overcoming product development hurdles
• The current state of the law regarding patenting diagnostic methods in the United States
• What’s on the horizon in the United States
• Global considerations for Europe and Asia